Toggle Main Menu Toggle Search

Open Access padlockePrints

Targeting tropomyosin receptor kinase in cutaneous CYLD defective tumors (TRAC): A randomised placebo-controlled early phase trial with pegcantratinib

Lookup NU author(s): Dr Marina Danilenko, Elaine Stamp, Dr Deborah Stocken, Monique Zangarini, Amy Cranston, Robert Stones, Naomi Sinclair, Kirsty Hodgson, Dr Susan Bowett, Professor Ruth Plummer, Professor Gareth Veal, Dr James Langtry, Professor Sir John Burn, Dr Neil Rajan



This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Danilenko M, Stamp E, Stocken DD, Husain A, Zangarini M, Cranston A, Stones R, Sinclair N, Hodgson K, Bowett SA, Roblin D, Traversa S, Plummer R, Veal G, Langtry JAA, Ashworth A, Burn J, Rajan N

Publication type: Article

Publication status: Published

Journal: JAMA Dermatology

Year: 2018

Volume: 154

Issue: 8

Pages: 913-921

Print publication date: 01/08/2018

Online publication date: 27/06/2018

Acceptance date: 18/04/2018

Date deposited: 03/07/2018

ISSN (print): 2168-6068

ISSN (electronic): 2168-6084

Publisher: American Medical Association


DOI: 10.1001/jamadermatol.2018.1610


Altmetrics provided by Altmetric


Find at Newcastle University icon    Link to this publication